Author:
Almuhtaseb H,Johnston R L,Talks J S,Lotery A J
Publisher
Springer Science and Business Media LLC
Reference10 articles.
1. Bourne RR, Jonas JB, Flaxman SR, Keeffe J, Leasher J, Naidoo K et al. Prevalence and causes of vision loss in highincome countries and in Eastern and Central Europe: 1990- 2010. Br J Ophthalmol 2014; 98 (5): 629–638.
2. Sarwar S, Clearfield E, Soliman MK, Sadiq MA, Baldwin AJ, Hanout M et al. Aflibercept for neovascular age-related macular degeneration. Cochrane Database Syst Rev 2016; 2: CD011346.
3. Heier JS, Brown DM, Chong V, Korobelnik JF, Kaiser PK, Nguyen QD et al. Intravitreal aflibercept (VEGF Trap-Eye) in wet age-related macular degeneration. Ophthalmology 2012; 119: 2537–2548.
4. Talks JS, Lotery AJ, Ghanchi F, Sivaprasad S, Johnston RL, Patel N et al. First-year visual acuity outcomes of providing aflibercept according to the VIEW study protocol for age-related macular degeneration. Ophthalmol 2016; 123 (2): 337–343.
5. Schmidt-Erfurth U, Kaiser PK, Korobelnik J-F, Brown DM, Chong V, Nguyen QD et al. Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies. Ophthalmology 2014; 121 (1): 193–201.
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献